Bioadaptives, Inc. SEC filings BDPT

Bioadaptives, Inc. has 176 filings in SEC EDGAR's recent list, going back to May 3, 2013. Its latest annual report, Form 10-K, was filed on Apr 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Apr 14, 2026 Dec 31, 2025
10-K Annual report Apr 15, 2025 Dec 31, 2024
10-K Annual report Apr 10, 2024 Dec 31, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2022 Dec 31, 2021
10-K Annual report Mar 30, 2021 Dec 31, 2020
10-K/A Amended annual report May 12, 2020 Dec 31, 2019
10-K Annual report May 1, 2020 Dec 31, 2019
10-K Annual report Apr 14, 2016 Dec 31, 2015
10-K Annual report Apr 15, 2015 Dec 31, 2014
10-K Annual report Apr 14, 2014 Dec 31, 2013

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BDPT (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Las Vegas, NV
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1575142
Former names
APEX 8 Inc. (until Aug 19, 2013)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.